NCT02352792Unknown不适用
Randomized Phase II Study for Dose Escalation in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated With Radiochemotherapy
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 90
- 试验地点
- 2
- 主要终点
- time to local recurrence
研究概览
简要总结
Patients with locally advanced suqamous cell carcinoma of the head and neck region receive a hypoxia scan either by magnetic resonance tomography, computed tomography or fluoromisonidazole (FMISO)-PET-CT. Patients presenting with hypoxia are randomized into standard therapy consisting of intensity modulated radiotherapy (IMRT) with 70 Gy plus either 5-fluorouracil/mitomycin C or cisplatinum (Arm A) or a dose escalation of 10% (77Gy) to the hypoxic volume applied via simultaneous integrated boost in addition to the standard treatment (Arm B).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •histologically verified squamous cell carcinoma of the head and neck region stage III and IV eligible for primary radiochemotherapy
- •measurabel disease by CT and/or MRT and/or FDG-PET-CT
- •fit for chemotherapy
- •no prior radiotherapy or major surgery in the head/neck region
- •Karnofsky Index > 60%
- •informed consent
排除标准
- •uncontrolled secondary cancer
- •distant metastases
- •pregnancy
- •expected malcompliance
结局指标
主要结局
time to local recurrence
时间窗: 5 years
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCCSquamous Cell Carcinoma of Head and NeckNCT04688528Universitaire Ziekenhuizen KU Leuven147
Unknown
1 期
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory GatingCarcinoma, Non-Small-Cell LungNCT00690963AHS Cancer Control Alberta12
Unknown
2 期
Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung CancerStage III Non-Small Cell Lung CancerNCT00938418National University Hospital, Singapore43
已完成
不适用
Assessment of tumor hypoxia in laryngeal cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET/CT scanning, oxygen-enhanced MRI (OE-MRI) and immunohistochemistryvocal cord cancerNL-OMON33970niversitair Medisch Centrum Groningen12
已完成
2 期
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckHead and Neck CancerNCT02823574Bristol-Myers Squibb425